CASC Stock Ownership Activity

CASCADIAN THERAPEUTICS INC 13F holders

No value investing guru has made any change to the CASCADIAN THERAPEUTICS INC (CASC) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying CASC now?

According to the latest SEC filing(s) CASCADIAN THERAPEUTICS INC (CASC) has not been purchased by any super investor.

To see more about who is investing in CASCADIAN THERAPEUTICS INC (CASC), please go to the CASC ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2018 Q1 (1 result)
Seth Klarman
Baupost Group
-100.00%
-5,930,333
-0.31%
0.00%
Reported price*: $3.70
2017 Q1 (1 result)
Seth Klarman
Baupost Group
+109.31%
+4,554,413
+0.22%
0.43%
Reported price*: $4.14
2016 Q4 (1 result)
Seth Klarman
Baupost Group
buy
+4,166,666
+0.24%
0.24%
Reported price*: $4.31
3 of 3

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.